EcoDrugPlus

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSPREG00000011925
Gene Symbol: LOC103465921
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPREG00000021802
Gene Symbol: AVPR1A
1 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPREG00000020474
Gene Symbol: AVPR2
3 Cross references
148 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPREG00000022030
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Aromatase

Ensembl ID : ENSPREG00000012213
Gene Symbol: LOC103462065
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2

Ensembl ID : ENSPREG00000020297
Gene Symbol: LOC103473991
2 Cross references
185 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSPREG00000008806
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSPREG00000013954
Gene Symbol: LOC103471497
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSPREG00000004394
Gene Symbol: LOC103466909
3 Cross references
226 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSPREG00000007294
Gene Symbol: LOC103470523
3 Cross references
196 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSPREG00000007607
Gene Symbol: LOC103475673
2 Cross references
192 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPREG00000007495
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).